1 in 5 women suffer from heavy menstrual bleeding1, and account for 12% of all gynaecology referrals.2

Transitioning the NovaSure® procedure from a theatre to an outpatient setting can help to reduce the backlog of untreated patients, save costs*, minimise risks and improve patient care.

Contact us today find out more

NovaSure is the market leading endometrial ablation technology in the UK, with 90% of hospitals already using the treatment.3

The British Association of Day Surgery singled out ‘endometrial ablation’ in the National Day Surgery Delivery Pack supported by GIRFT, as a ‘Key Procedure to move from day surgery to the outpatient setting’.4
Despite this, only 50% of Trusts currently offering the procedure have 'made the move' to the outpatient setting.4
East Suffolk and North Essex NHS Foundation Trust have made the move to outpatients with NovaSure, watch the video to learn more about their experience:

UK survey of Hospitals offering NovaSure in Outpatients

A recent survey of hospital experiences offering NovaSure in outpatients across the UK

Why MAKE THE MOVE to outpatients to streamline Women's Services in your Trust?

Reduce your patient backlog

Are you facing the challenge of reducing the backlog of patients awaiting surgical procedures?
Using an outpatient setting for NovaSure procedures creates a more streamlined treatment pathway, with waiting times becoming proportionally shorter. Increasing capacity to reduce the backlog of patients awaiting treatment.

Reduce costs for your Trust

Did you know? You can reduce endometrial ablation procedure costs for your hospital by approx. £1000/patient*.
All it takes is one simple change. Move your NovaSure® endometrial ablation services to outpatients.
This change also improves the patient experience.5 The procedure can be performed without undergoing a general anaesthetic, resulting in:
  • Less time in hospital
  • Shorter recovery time
  • Less risk of infection
  • Less time off work


To learn more about the positive impact of moving minimally invasive surgical treatments for AUB and HMB to the outpatient department.
Download the infographic


Find out more about how East Suffolk & North Essex Foundation Trust moved their NovaSure Endometrial Ablation procedures to Outpatient Gynaecology.
Download the case study

Hologic has supported many NHS Trusts to MAKE THE MOVE and experience the benefits of transitioning NovaSure to the outpatient department.

Contact Us today to find out more and learn how we can support you.

References: 1. Royal College of Obstetricians & Gynaecologists [Internet]. National Heavy Menstrual Bleeding Audit, July 2014. Available at: [] Last accessed 1st June 2021 2. National Institute for Health and Care Excellence [Internet]. Guideline on Heavy menstrual bleeding: assessment and management (NG88) 2018. Available at: [] Last accessed 1st June 2021 3. Hologic Data on File – June 2021 4. Getting It Right First Time [Internet] The National Day Surgery Delivery Pack (Sept 2020) page 45. Available at: Last accessed 8th June 2021 5. Kremer C, Duffy S, Moroney M. Patient satisfaction with outpatient hysteroscopy versus day case hysteroscopy: randomised controlled trial. BMJ, 2000; 320:279-82

*DISCLAIMER: Hologic Ltd has used reasonable efforts to provide accurate costing advice, but this advice should not be construed as providing clinical advice, dictating reimbursement policy or substituting for the judgment of a Practitioner. It is always the provider’s responsibility to determine and submit appropriate codes, charges and modifiers for services that are rendered. Provider is responsible for verifying reimbursement coverage. Hologic Ltd assumes no responsibility for the timeliness, accuracy and completeness of the information contained herein. Since reimbursement policy and regulations change frequently, it is recommended that providers consult with the relevant coding department regarding reimbursement coverage. Hologic UK has based treatment/hospitalisation times on the reference indicated and customer experience.

WEB-01305-EUR-EN Rev 001